Targeted Oral Therapies in Progressive Small Bowel Neuroendocrine Tumor: Everolimus and Cabozantinib
Cabozantinib is presented as an emerging option with activity across extrapancreatic neuroendocrine tumors. Dr Lieu highlights its distinct mechanism of action and discusses how it expands treatment ...
The speakers emphasize that symptom burden can alter sequencing priorities and prompt greater integration of supportive interventions alongside tumor directed therapy. Regular symptom assessment and ...
Obscure gastrointestinal (GI) bleeding creates a diagnostic challenge for gastroenterologists. Many patients undergo multiple blood transfusions and repeated studies. Modern imaging techniques improve ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine A study published in Nature suggests a variation in ...
Why Are Small Bowel Tumors So Rare? Medscape: Considering that the small bowel comprises the largest overall surface area of the lower gastrointestinal tract, why are small bowel cancers less common ...
In a recent study published in the journal Frontiers in Immunology, researchers investigate the impact of dietary antigens in regulating small intestinal tumors. Despite being the most common type of ...
Please provide your email address to receive an email when new articles are posted on . Celiac patients had higher risks for pancreatic, esophageal, colonic and gastric cancers but not rectal cancer ...
Researchers have developed a human intestinal cell model that closely mimics the structure and function of the human gut, enabling more precise prediction of drug-induced gastrointestinal toxicity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results